For 35 years, the FDA has placed onerous restrictions on the only drug it has ever approved for treatment-resistant ...

"FDA has notified the manufacturers that the clozapine REMS must be eliminated," the agency said. "FDA has instructed the ...

Advocates and clinicians say that patients are still having trouble getting refills, even though the FDA has lifted REMS for ...

Cognitive behavioral therapy, periodic communication after suicide attempt, and pharmacologic treatments are important tools for veteran treatment.

Patients will no longer need to provide blood test results before they can get clozapine prescriptions filled, according to ...

NAMI released the following statement from Chief Executive Officer Daniel H. Gillison, Jr., following the Food and Drug Administration (FDA) announcement on February 24 that they will remove ...

Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window Most physicians said the positives of clozapine's REMS outweighed its negatives. Most also said that mandatory blood ...

By Ellen Barry The Food and Drug Administration has taken a crucial step toward expanding access to the antipsychotic medication clozapine, the only drug approved for treatment-resistant ...

(HealthDay News) — The U.S. Food and Drug Administration has removed one hurdle faced by patients with schizophrenia when filling prescriptions for the antipsychotic medication clozapine.

A coroner has written to five national organisations after a man vomited to death while taking an anti-psychotic, warning ...

A third of people with schizophrenia have symptoms that will not sufficiently respond to two adequate trials of antipsychotic medications.1 For these people with treatment-resistant schizophrenia, ...

Most physician prescribers were satisfied with the FDA's controversial risk evaluation and mitigation strategy (REMS) program for clozapine, survey data showed. Among 196 doctors who prescribed ...